Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.5000
-0.2500 (-33.33%)
Oct 7, 2025, 1:56 PM EDT
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $723.15 thousand as of October 8, 2025. Its market cap has decreased by -97.39% in one year.
Market Cap
723.15K
Enterprise Value
17.78M
Revenue
899.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.50
Market Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 723.15K, an increase of 185.91%. That is a compound annual growth rate of 7.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 723.15K | -92.64% |
| Dec 31, 2024 | 9.83M | -38.42% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | 108.70M | 44.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |